JP2024519814A5 - - Google Patents
Info
- Publication number
- JP2024519814A5 JP2024519814A5 JP2023571295A JP2023571295A JP2024519814A5 JP 2024519814 A5 JP2024519814 A5 JP 2024519814A5 JP 2023571295 A JP2023571295 A JP 2023571295A JP 2023571295 A JP2023571295 A JP 2023571295A JP 2024519814 A5 JP2024519814 A5 JP 2024519814A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- salt
- compound
- target
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189522P | 2021-05-17 | 2021-05-17 | |
| US63/189,522 | 2021-05-17 | ||
| PCT/US2022/029535 WO2022245759A2 (en) | 2021-05-17 | 2022-05-17 | Agents for directed conjugation techniques and conjugated products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519814A JP2024519814A (ja) | 2024-05-21 |
| JP2024519814A5 true JP2024519814A5 (enExample) | 2025-05-23 |
Family
ID=84140970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571295A Pending JP2024519814A (ja) | 2021-05-17 | 2022-05-17 | 指向性コンジュゲーション技術のための薬剤及びコンジュゲート生成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240252674A1 (enExample) |
| EP (1) | EP4340891A4 (enExample) |
| JP (1) | JP2024519814A (enExample) |
| KR (1) | KR20240012380A (enExample) |
| CN (1) | CN117750979A (enExample) |
| AU (1) | AU2022275832A1 (enExample) |
| CA (1) | CA3219517A1 (enExample) |
| IL (1) | IL307799A (enExample) |
| MX (1) | MX2023013272A (enExample) |
| PH (1) | PH12023553154A1 (enExample) |
| WO (1) | WO2022245759A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023013274A (es) * | 2021-05-17 | 2023-11-30 | Biohaven Therapeutics Ltd | Composiciones que incluyen potenciadores de tratamientos conjugados. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US20140079636A1 (en) * | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| RU2698697C2 (ru) * | 2013-12-23 | 2019-08-29 | Байер Фарма Акциенгезельшафт | Конъюгаты связующего (ADC) с ингибиторами KSP |
| WO2017042944A1 (ja) * | 2015-09-10 | 2017-03-16 | 国立大学法人山梨大学 | フィラデルフィア染色体陽性（Ｐｈ＋）急性リンパ性白血病（ＡＬＬ）の治療薬又は治療方法 |
| AU2018259856B2 (en) * | 2017-04-28 | 2025-05-01 | Ajinomoto Co., Inc. | Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof |
| CA3069986A1 (en) * | 2017-07-26 | 2019-01-31 | Kleo Pharmaceuticals, Inc. | Universal abt compounds and uses thereof |
| CA3075778A1 (en) * | 2017-09-18 | 2019-03-21 | Trustees Of Boston University | Methods for treating netosis and neutrophil activation |
| US10953107B2 (en) * | 2018-06-15 | 2021-03-23 | Trustees Of Boston University | Polypeptide compositions and methods for site-specific targeting of therapeutic agents |
| US20230028880A1 (en) * | 2019-07-03 | 2023-01-26 | Biohaven Therapeutics Ltd. | Cd38-binding agents and uses thereof |
-
2022
- 2022-05-17 CA CA3219517A patent/CA3219517A1/en active Pending
- 2022-05-17 EP EP22805274.2A patent/EP4340891A4/en active Pending
- 2022-05-17 WO PCT/US2022/029535 patent/WO2022245759A2/en not_active Ceased
- 2022-05-17 MX MX2023013272A patent/MX2023013272A/es unknown
- 2022-05-17 AU AU2022275832A patent/AU2022275832A1/en active Pending
- 2022-05-17 IL IL307799A patent/IL307799A/en unknown
- 2022-05-17 PH PH1/2023/553154A patent/PH12023553154A1/en unknown
- 2022-05-17 US US18/555,857 patent/US20240252674A1/en active Pending
- 2022-05-17 CN CN202280034207.3A patent/CN117750979A/zh active Pending
- 2022-05-17 JP JP2023571295A patent/JP2024519814A/ja active Pending
- 2022-05-17 KR KR1020237039500A patent/KR20240012380A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6942147B2 (ja) | Ｍｔ１−ｍｍｐに対して特異的な二環式ペプチド−毒素コンジュゲート | |
| JP2021098755A (ja) | 新規なポリペプチド | |
| JP2023501720A5 (enExample) | ||
| EP2651964B1 (en) | Cross-linked peptides and proteins, methods of making same, and uses thereof | |
| JP2020529427A (ja) | Ｃｄ１３７に対して特異的な二環式ペプチドリガンド | |
| JP2022517698A (ja) | インテグリンαｖβ３に特異的な二環式ペプチドリガンド | |
| JP2022514687A (ja) | Ｐｄ－ｌ１に特異的な二環式ペプチドリガンド | |
| JP2021507909A (ja) | ＥｐｈＡ２に特異的な二環ペプチドリガンド | |
| JP2022517442A (ja) | Ｃａｉｘに特異的な二環式ペプチドリガンド | |
| JP2022518210A (ja) | インテグリンαｖβ３に特異的な二環式ペプチドリガンド | |
| EP3432935B1 (en) | Site-specific bio-conjugation methods and compositions useful for nanopore systems | |
| AU2022234694B2 (en) | Compound or salt thereof, and antibody obtained using same | |
| JP2024519814A5 (enExample) | ||
| JP2021535108A5 (enExample) | ||
| AU2022208654B2 (en) | Compound or salt thereof, and antibody produced using same | |
| JP2024521092A5 (enExample) | ||
| US8829157B2 (en) | Process for the synthesis of cyclic heptapeptide | |
| CN105254655B (zh) | 一种基于bodipy的荧光氨基酸及其合成方法与应用 | |
| JP6977058B2 (ja) | ピクテ・スペングラー反応を介して得られたタグ付けヌクレオシドを用いたシーケンシング反応のための方法 | |
| WO2020195302A1 (ja) | 細胞膜透過性環状ペプチド作製用リンカー分子、及びその利用 | |
| US12351619B2 (en) | Serum albumin-binding fibronectin type III domains and uses thereof | |
| JPH06239898A (ja) | 免疫抱合体の調製法 | |
| JP2024519814A (ja) | 指向性コンジュゲーション技術のための薬剤及びコンジュゲート生成物 | |
| KR102843184B1 (ko) | 다이머 펩타이드-인지질 콘쥬게이트를 위한 최적화 과정 | |
| WO2016060096A1 (ja) | ホスホリルコリン基含有化合物およびホスホリルコリン複合体 |